slide-01 slide-02 Screen4

Technology Platform

image-01

VaxInnate's Technology Platform is revolutionizing how vaccines are created and produced.

Explore

Product Pipeline

image-02

Learn more about our vaccines currently in our development pipeline

View

In The News

VAX2012Q-90

08 Oct 2014 - VaxInnate Updates Plans to Advance Lead Vaccine Candidate, VAX2012Q in Elderly

CRANBURY, NJ, October 8, 2014 – VaxInnate Corporation, a biotechnology firm pioneering a breakthrough vaccine technology platform, provided an update on clinical development plans for the Company’s experimental recombinant quadrivalent vaccine, VAX2012Q. VaxInnate plans to advance VAX2012Q into a Phase 1b/2 study for the prevention of seasonal influenza in elderly individuals by the end of […]

Read